We are live on
!
Find out more
ACM
Anfield Capital Management Portfolio holdings
AUM
$363M
1-Year Est. Return
24.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
–
AUM
$290M
AUM Growth
-$30.6M
(-9.5%)
Cap. Flow
-$42.9M
Cap. Flow
% of AUM
-14.8%
Top 10 Holdings %
Top 10 Hldgs %
62.46%
Holding
137
New
12
Increased
62
Reduced
18
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$5.7M |
| 2 |
ADFI
Anfield Dynamic Fixed Income ETF
ADFI
|
+$2.85M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$2.35M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.21M |
| 5 |
Apple
AAPL
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$12.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$11.2M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.55M |
| 4 |
iShares Preferred and Income Securities ETF
PFF
|
+$3.33M |
| 5 |
iShares MBS ETF
MBB
|
+$3.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 2.85% |
| 2 | Technology | 2.41% |
| 3 | Real Estate | 2.12% |
| 4 | Healthcare | 0.58% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Danaher
DHR
$144B
| $201K | 0.07% |
688
+644
| +1,464% | +$177K |
|
77
Intuitive Surgical
ISRG
$134B
| $128K | 0.04% |
355
+319
| +886% | +$110K |
|
78
Regeneron Pharmaceuticals
REGN
$80.8B
| $114K | 0.04% |
181
+165
| +1,031% | +$101K |
|
79
BioNTech
BNTX
$23.5B
| $112K | 0.04% |
436
+398
| +1,047% | +$109K |
|
80
Vertex Pharmaceuticals
VRTX
$126B
| $97K | 0.03% |
440
+400
| +1,000% | +$77.8K |
|
|
FT
81
Franklin Universal Trust
FT
$197M
| $96K | 0.03% |
11,391
-1,174
| -9% | -$9.69K |
|
|
GUT
82
Gabelli Utility Trust
GUT
$559M
| $93K | 0.03% |
11,519
-1,230
| -10% | -$9.68K |
|
83
Agilent Technologies
A
$41.2B
| $81K | 0.03% |
507
+461
| +1,002% | +$71.8K |
|
84
BlackRock Income Trust
BKT
$341M
| $78K | 0.03% |
4,621
-477
| -9% | -$8.49K |
|
85
Labcorp
LH
$25.9B
| $54K | 0.02% |
199
+182
| +1,071% | +$45.1K |
|
86
Quest Diagnostics
DGX
$26.3B
| $37K | 0.01% |
212
+194
| +1,078% | +$29.5K |
|
87
Qiagen
QGEN
$8.72B
| $24K | 0.01% |
400
+366
| +1,076% | +$21K |
|
88
Encompass Health
EHC
$12.4B
| $12K | ﹤0.01% |
233
+214
| +1,126% | +$11K |
|
|
BPMC
89
DELISTED
Blueprint Medicines
BPMC
| $11K | ﹤0.01% |
106
+98
| +1,225% | +$10.3K |
|
|
CPRX
90
DELISTED
Catalyst Pharmaceutical
CPRX
| $11K | ﹤0.01% |
1,593
+1,468
| +1,174% | +$9.65K |
|
91
Halozyme
HALO
$12.2B
| $11K | ﹤0.01% |
267
+246
| +1,171% | +$9.18K |
|
92
CRISPR Therapeutics
CRSP
$5.17B
| $10K | ﹤0.01% |
136
+125
| +1,136% | +$10.9K |
|
93
InMode
INMD
$880M
| $9K | ﹤0.01% |
125
+115
| +1,150% | +$9.22K |
|
94
Innoviva
INVA
$1.48B
| $9K | ﹤0.01% |
546
+505
| +1,232% | +$8.6K |
|
|
PINC
95
DELISTED
Premier
PINC
| $9K | ﹤0.01% |
222
+205
| +1,206% | +$8.09K |
|
96
QuidelOrtho
QDEL
$838M
| $9K | ﹤0.01% |
70
+65
| +1,300% | +$9.05K |
|
97
Ironwood Pharmaceuticals
IRWD
$714M
| $8K | ﹤0.01% |
684
+633
| +1,241% | +$7.77K |
|
|
SAGE
98
DELISTED
Sage Therapeutics
SAGE
| $8K | ﹤0.01% |
187
+173
| +1,236% | +$7.24K |
|
99
Organogenesis Holdings
ORGO
$239M
| $5K | ﹤0.01% |
564
+523
| +1,276% | +$5.55K |
|
100
uniQure
QURE
$3.22B
| $5K | ﹤0.01% |
261
+243
| +1,350% | +$6.97K |
|
Similar funds
RGC
VIA
RC
MS
WI
DCP
HS
SIAG
Anfield Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Anfield Capital Management held 137 positions worth $290M, down 9.5% from $321M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Anfield Capital Management withdrew a net $42.9M in Q4 2021, closing 37 positions and reducing 18 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 2.8% of assets, down from 2.9% a quarter earlier, followed by Technology and Real Estate.
Against the trend, Anfield Capital Management opened a new position in State Street Materials Select Sector SPDR ETF worth $5.98M.
- Anfield Capital Management's largest Q4 2021 buy was State Street Materials Select Sector SPDR ETF: 132,068 shares worth $5.98M.
- Anfield Capital Management added most to State Street Industrial Select Sector SPDR ETF in Q4 2021, an estimated $2.35M increase.
- Anfield Capital Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $12.1M.
- Anfield Capital Management fully exited Invesco QQQ Trust in Q4 2021, selling an estimated $11.2M.
- Anfield Capital Management's ten largest holdings make up 62% of its $290M portfolio in Q4 2021.
- Anfield Capital Management opened 12 new positions and closed 37 in Q4 2021.
- Anfield Capital Management's portfolio value fell 9.5% quarter-over-quarter to $290M.
Based on Anfield Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.